Systematic review / meta-analysis / 2014
Flaxseed intake is linked to lower breast cancer risk and improved survival
A systematic review examined 10 studies evaluating flaxseed and breast cancer. In randomized trials of newly diagnosed patients, 25 g daily of flax increased apoptotic index and reduced HER2 expression (both P < 0.05) relative to control. Observational investigations linked flax intake to lower primary breast cancer incidence (OR = 0.82; 95% CI: 0.69-0.97) and lower mortality (HR = 0.69; 95% CI: 0.50-0.95).
- Study type
- Systematic review of clinical trials and observational studies
- Who was studied
- 10 clinical and observational studies in women
- What was measured
- Breast cancer risk, mortality, tumor biomarkers, and menopausal symptoms
THE PAPER
Flax and Breast Cancer: A Systematic Review.
Flower G, Fritz H, Balneaves LG, Verma S, Skidmore B, Fernandes R, Kennedy D, Cooley K, Wong R, Sagar S, Fergusson D, Seely D. Integr Cancer Ther, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.